Bill > HB2434

This bill makes several changes to Arizona's controlled substances prescription monitoring program, aiming to improve tracking and reporting of prescription drugs. Key provisions include updating the definition of a "compliance workgroup" to focus on identifying noncompliance with the program, and modifying reporting requirements for dispensers to include the date a prescription was sold to the ultimate user and to report zero transactions if none occurred, with a requirement to submit this information within one business day after the sale. The bill also clarifies that prescription information submitted to the board is confidential and outlines specific circumstances under which it can be released, such as to authorized prescribers or dispensers for patient care, to law enforcement with a warrant, or for statistical and research purposes after personal identifying information is removed. Additionally, it mandates that medical practitioners and pharmacists must register with the board and access the prescription monitoring program, and clarifies that practitioners must obtain a patient utilization report from the program before prescribing certain controlled substances, with specific exceptions for situations like hospice care or acute pain treatment. The bill also updates language regarding the use of electronic prescribing systems and the responsibilities of those accessing the program's data.

Health and Social Services

https://apps.azleg.gov/BillStatus/BillOverview/84205